732450947	732450947	CD	B-NP	O
|	|	NN	I-NP	O
FAH	FAH	NN	I-NP	O
|	|	NN	I-NP	O
42171941	42171941	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1561926	1561926	CD	B-NP	O
|	|	CC	I-NP	O
9/14/2005	9/14/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/13/2005	1/13/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
GEORGE	GEORGE	NNP	B-NP	O
HONG	HONG	NNP	I-NP	O
MARSKE	MARSKE	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Bradycardia	Bradycardia	NNP	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
and	and	CC	I-NP	O
plantar	plantar	NN	I-NP	O
fasciitis	fasciitis	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
treated	treat	VBN	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
includes	include	VBZ	B-VP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Operations	Operation	NNS	B-NP	O
and	and	CC	I-NP	O
procedures	procedure	NNS	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
include	include	VBP	B-VP	O
colonoscopy	colonoscopy	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
other	other	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
brief	brief	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sitting	sit	VBG	I-VP	O
at	at	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
in	in	IN	B-PP	O
drowsiness	drowsiness	NN	B-NP	O
and	and	CC	I-NP	O
faintness	faintness	NN	I-NP	O
with	with	IN	B-PP	O
gradual	gradual	JJ	B-NP	O
onset	onset	NN	I-NP	O
over	over	IN	B-PP	O
ten	ten	CD	B-NP	O
minutes	minute	NNS	I-NP	O
while	while	IN	B-SBAR	O
seated	seat	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
felt	feel	VBD	B-VP	O
as	as	IN	B-SBAR	O
if	if	IN	I-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	B-PP	O
collapse	collapse	NN	B-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
visual	visual	JJ	I-NP	O
or	or	CC	I-NP	O
motor	motor	NN	I-NP	O
deficit	deficit	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
called	call	VBD	B-VP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
no	no	DT	B-NP	O
dysarthria	dysarthria	NN	I-NP	O
or	or	CC	I-NP	O
confusion	confusion	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
motor	motor	NN	I-NP	O
deficit	deficit	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
stood	stand	VBD	B-VP	O
and	and	CC	I-VP	O
walked	walk	VBD	I-VP	O
outside	outside	IN	B-PP	O
noting	note	VBG	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
standing	standing	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fall	fall	NN	B-NP	O
or	or	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
30	30	CD	I-NP	O
feet	foot	NNS	I-NP	O
without	without	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
ten	ten	CD	I-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cough	cough	NN	I-NP	O
but	but	CC	O	O
mild	mild	JJ	B-NP	O
URI	URI	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
subjective	subjective	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
stools	stool	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
burning	burning	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
falls	fall	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
presentations	presentation	NNS	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
for	for	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
her	her	PRP$	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
repeatedly	repeatedly	RB	I-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Clonidine	Clonidine	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Past	Past	NNP	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
PPD	PPD	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
which	which	WDT	B-NP	O
gives	give	VBZ	B-VP	O
her	her	PRP$	B-NP	O
angioedema	angioedema	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
CT	CT	NN	B-NP	B-protein
contrast	contrast	NN	I-NP	I-protein
dye	dye	NN	I-NP	I-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
Avapro	Avapro	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Clonidine	Clonidine	NN	B-NP	O
0.2	0.2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
20	20	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Flonase	Flonase	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiovascular	cardiovascular	JJ	B-NP	O
or	or	CC	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
95.5	95.5	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
140/60	140/60	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
fatigued	fatigue	VBN	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
scleral	scleral	JJ	I-NP	O
icterus	icterus	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
is	be	VBZ	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
are	be	VBP	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
without	without	IN	B-PP	O
wheezes	wheeze	NNS	B-NP	O
or	or	CC	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pulsatile	pulsatile	JJ	I-NP	O
liver	liver	NN	I-NP	O
is	be	VBZ	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
reflexes	reflex	NNS	I-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
5/5	5/5	CD	B-NP	O
strength	strength	NN	I-NP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
are	be	VBP	B-VP	O
all	all	DT	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Admission	Admission	NN	B-NP	O
labs	lab	NNS	I-NP	O
are	be	VBP	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
35.8	35.8	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
essentially	essentially	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
returned	return	VBN	I-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
2.55	2.55	CD	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
low	low	JJ	B-NP	O
lung	lung	NN	I-NP	O
volumes	volume	NNS	I-NP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
without	without	IN	B-PP	O
effusion	effusion	NN	B-NP	O
or	or	CC	I-NP	O
consolidation	consolidation	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
40	40	CD	I-NP	O
bpm	bpm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
Q	Q	NN	I-NP	O
waves	wave	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
or	or	CC	I-NP	O
depression	depression	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
QT	QT	NN	I-NP	O
corrected	correct	VBN	B-VP	O
is	be	VBZ	B-VP	O
431	431	CD	B-NP	O
milliseconds	millisecond	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	JJ	I-NP	O
January	January	NNP	I-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
showing	show	VBG	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
normal	normal	JJ	I-NP	O
valves	valve	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
workup	workup	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
reviewing	review	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
records	record	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
experienced	experience	VBN	I-VP	O
similar	similar	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
medications	medication	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
longstanding	longstanding	JJ	I-NP	O
medication	medication	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Clonidine	Clonidine	NN	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
only	only	RB	I-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
preceding	precede	VBG	I-NP	O
2-3	2-3	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
nodal	nodal	JJ	B-NP	O
blocking	block	VBG	I-NP	O
properties	property	NNS	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
Clonidine	Clonidine	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
potential	potential	JJ	I-NP	O
rare	rare	JJ	I-NP	O
adverse	adverse	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
of	of	IN	B-PP	O
causing	cause	VBG	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
heart	heart	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
gradually	gradually	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
dictation	dictation	NN	B-NP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
60-75	60-75	CD	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
anginal	anginal	JJ	B-NP	O
chest	chest	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	O	O
worsening	worsen	VBG	B-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
Peley	Peley	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Health	Health	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
who	who	WP	B-NP	O
found	find	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
likely	likely	RB	B-ADJP	O
not	not	RB	O	O
to	to	TO	B-VP	O
require	require	VB	I-VP	O
pacemaker	pacemaker	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
additionally	additionally	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
Clonidine	Clonidine	NN	B-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
restarting	restart	VBG	I-VP	O
atenolol	atenolol	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
re-evaluated	re-evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Electrophysiology	Electrophysiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Tu	Tu	NNP	I-NP	O
Chihar	Chihar	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
which	which	WDT	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
likely	likely	RB	I-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
discontinuation	discontinuation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP	B-NP	O
nodally	nodally	RB	I-NP	O
active	active	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
or	or	CC	I-NP	O
dangerous	dangerous	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	O
x3	x3	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
to	to	TO	B-VP	O
indicate	indicate	VB	I-VP	O
myocardial	myocardial	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
or	or	CC	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pump	pump	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	I-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
chronic	chronic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
likely	likely	JJ	I-ADJP	O
not	not	RB	O	O
an	an	DT	B-NP	O
issue	issue	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
further	further	RBR	I-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
without	without	IN	B-PP	O
further	further	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
team	team	NN	I-NP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continue	continue	VB	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
Avapro	Avapro	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
poorly	poorly	RB	I-VP	O
controlled	control	VBN	I-VP	O
hypertension	hypertension	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
undergo	undergo	VB	I-VP	O
a	a	DT	B-NP	O
trial	trial	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
agent	agent	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
sinoatrial	sinoatrial	JJ	I-NP	O
node	node	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
recommended	recommended	JJ	I-NP	O
agent	agent	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
doxazosin	doxazosin	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
bradycardia	bradycardia	NN	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
medications	medication	NNS	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
controlled	control	VBN	B-VP	O
by	by	IN	B-PP	O
medications	medication	NNS	B-NP	O
that	that	WDT	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
re-evaluated	re-evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
electrophysiology	electrophysiology	NN	I-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
though	though	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
recommended	recommend	VBN	I-NP	O
electrophysiologic	electrophysiologic	JJ	I-NP	O
workup	workup	NN	I-NP	O
remaining	remain	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
known	know	VBN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diverticulosis	diverticulosis	NN	B-NP	O
by	by	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
barium	barium	NN	B-NP	O
enema	enema	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
suddenly	suddenly	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
rectum	rectum	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.5	1.5	CD	I-NP	O
-	-	HYPH	I-NP	O
2	2	CD	I-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
clearly	clearly	RB	B-ADJP	O
orthostatic	orthostatic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
unable	unable	JJ	I-ADJP	O
to	to	TO	B-VP	O
stand	stand	VB	I-VP	O
without	without	IN	B-PP	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
bleeding	bleeding	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hematemesis	hematemesis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
stabilizing	stabilize	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
30s	30	NNS	I-NP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
to	to	TO	B-PP	O
28.8	28.8	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Gastroenterology	Gastroenterology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
Nawsum	Nawsum	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Of	Of	IN	B-PP	O
who	who	WP	B-NP	O
took	take	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
colonscopy	colonscopy	NN	B-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
nonbleeding	nonbleeding	JJ	B-NP	O
diverticuli	diverticuli	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
was	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
made	make	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
diverticular	diverticular	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
currently	currently	RB	B-ADVP	O
stable	stable	JJ	B-ADJP	O
hemodynamically	hemodynamically	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
surgery	surgery	NN	B-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
but	but	CC	O	O
recommended	recommend	VBD	B-VP	O
nasogastric	nasogastric	JJ	B-NP	O
lavage	lavage	NN	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
rebleed	rebleed	VB	I-VP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
consultation	consultation	NN	I-NP	O
with	with	IN	B-PP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
drop	drop	NN	B-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
observation	observation	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
immediately	immediately	RB	B-ADVP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
and	and	CC	O	O
either	either	CC	O	O
vomiting	vomiting	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
or	or	CC	I-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	VBP	B-VP	O
following	follow	VBG	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
following	follow	VBG	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
50-60	50-60	CD	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
renovascular	renovascular	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
subsequently	subsequently	RB	I-VP	O
underwent	undergo	VBD	I-VP	O
a	a	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
workup	workup	NN	I-NP	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
an	an	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
cortisol	cortisol	NN	I-NP	O
level	level	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
10.8	10.8	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
aldosterone	aldosterone	NN	I-NP	O
level	level	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
2.8	2.8	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
and	and	CC	O	O
a	a	DT	B-NP	O
plasmin	plasmin	NN	I-NP	B-protein
renin	renin	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
0.1	0.1	CD	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
24	24	CD	I-NP	O
hour	hour	NN	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
urine	urine	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
metanephrines	metanephrine	NNS	I-NP	O
and	and	CC	I-NP	O
normetanephrines	normetanephrine	NNS	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	B-ADVP	O
outstanding	outstanding	JJ	B-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
these	these	DT	B-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
Norvasc	Norvasc	NNP	B-NP	O
and	and	CC	I-NP	O
Avapro	Avapro	NNP	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
dictation	dictation	NN	B-NP	O
her	her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
120	120	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
Beginning	Beginning	NN	B-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
foot	foot	NN	I-NP	O
cramps	cramp	NNS	I-NP	O
worse	worse	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
foot	foot	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
foot	foot	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
exacerbated	exacerbate	VBN	I-VP	O
by	by	IN	B-PP	O
dorsi	dorsi	NN	B-NP	O
and	and	CC	I-NP	O
plantar	plantar	NN	I-NP	O
flexion	flexion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
described	describe	VBD	B-VP	O
vague	vague	JJ	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
calves	calf	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
studies	study	NNS	I-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
venous	venous	JJ	B-NP	O
clots	clot	NNS	I-NP	O
in	in	IN	B-PP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
major	major	JJ	I-NP	O
joints	joint	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
frank	frank	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
to	to	TO	B-VP	O
likely	likely	RB	I-VP	O
have	have	VB	I-VP	O
plantar	plantar	NN	B-NP	O
fasciitis	fasciitis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
examination	examination	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
case	case	NN	I-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
Rheumatology	Rheumatology	NN	B-NP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
hot	hot	JJ	B-NP	O
or	or	CC	I-NP	O
cold	cold	JJ	I-NP	O
packs	pack	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
received	receive	VBD	B-VP	O
these	these	DT	B-NP	O
treatments	treatment	NNS	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
Rheumatology	Rheumatology	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
more	more	RBR	B-ADVP	O
fully	fully	RB	I-ADVP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
dictation	dictation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
walking	walk	VBG	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ENT	ENT	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Flonase	Flonase	NN	I-NP	B-protein
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-ADJP	O
without	without	IN	B-PP	O
new	new	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
dictation	dictation	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
diverticular	diverticular	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
PLAN	PLAN	NNP	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
plan	plan	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
is	be	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ernzen	Ernzen	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Spulick	Spulick	NNP	I-NP	O
is	be	VBZ	B-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
urinary	urinary	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
24	24	CD	I-NP	O
hour	hour	NN	I-NP	O
urine	urine	NN	I-NP	O
metanephrines	metanephrine	NNS	I-NP	O
and	and	CC	O	O
normetanephrine	normetanephrine	NN	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
his	his	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
closely	closely	RB	B-ADVP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
and	and	CC	I-VP	O
use	use	VB	I-VP	O
whenever	whenever	WRB	B-ADVP	O
possible	possible	JJ	B-NP	O
agents	agent	NNS	I-NP	O
without	without	IN	B-PP	O
sinoatrial	sinoatrial	JJ	B-NP	O
nodal	nodal	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Recommended	Recommend	VBN	B-VP	O
next	next	JJ	B-NP	O
agent	agent	NN	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
refractory	refractory	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
doxazosin	doxazosin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	I-VP	O
pursue	pursue	VB	I-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
fiber	fiber	NN	I-NP	O
diet	diet	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
medical	medical	JJ	B-NP	O
care	care	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
if	if	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
any	any	DT	B-NP	O
new	new	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
assessed	assess	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
likely	likely	JJ	I-NP	O
medication	medication	NN	I-NP	O
related	relate	VBN	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
return	return	VBP	B-VP	O
for	for	IN	B-PP	O
re-evaluation	re-evaluation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Electrophysiology	Electrophysiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Podiatry	Podiatry	NN	B-NP	O
if	if	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
note	note	VBP	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
NPH	NPH	NN	I-NP	O
insulin	insulin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
level	level	NN	I-NP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
14	14	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-VP	O
b.i.d.	b.i.d.	RB	I-VP	O
given	give	VBN	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
advised	advise	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
check	check	NN	I-NP	O
daily	daily	JJ	I-NP	O
fingersticks	fingerstick	NNS	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	O	O
adjust	adjust	VB	B-VP	O
her	her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	O
dosing	dosing	NN	I-NP	O
as	as	IN	B-PP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Discharge	Discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
will	will	MD	B-VP	O
include	include	VB	I-VP	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
14	14	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	I-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Flonase	Flonase	NN	B-NP	O
1-2	1-2	CD	B-NP	O
sprays	spray	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Avapro	Avapro	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-9438671	0-9438671	CD	B-NP	O
DBSSten	DBSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
OLWIN	OLWIN	NNP	B-NP	O
,	,	,	O	O
JOHNATHON	JOHNATHON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LECKBAND	LECKBAND	NNP	B-NP	O
,	,	,	O	O
JONATHON	JONATHON	NNP	B-NP	O
RUSSELL	RUSSELL	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6491482	6491482	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/24/05	10/24/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/24/05	10/24/05	CD	B-NP	O

